Spyre Therapeutics, Inc. (SYRE)
34.39
+0.03
(+0.09%)
USD |
NASDAQ |
Dec 12, 11:12
Spyre Therapeutics Free Cash Flow: -162.30M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| PTC Therapeutics, Inc. | 446.25M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
| Oragenics, Inc. | -8.429M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -37.12M |
| Cash from Investing (Quarterly) | 25.00M |
| Cash from Financing (Quarterly) | -4.643M |
| Free Cash Flow Per Share (Quarterly) | -0.6107 |
| Free Cash Flow to Equity (Quarterly) | -37.12M |
| Free Cash Flow to Firm (Quarterly) | -37.12M |
| Free Cash Flow Yield | -7.97% |